SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-028166
Filing Date
2018-05-14
Accepted
2018-05-14 16:01:23
Documents
3
Period of Report
2018-05-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv493947_8k.htm 8-K 18422
2 EXHIBIT 3.1 tv493947_ex3-1.htm EX-3.1 3550
3 EXHIBIT 3.2 tv493947_ex3-2.htm EX-3.2 48455
  Complete submission text file 0001144204-18-028166.txt   71680
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 18830503
SIC: 2834 Pharmaceutical Preparations